# Annemieke Wouterse

> Annemieke Wouterse is a seed investor at NV NOM backing Health Diagnostics and Health Care. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [NV NOM](https://shizune.co/investors/profile/nvnom)
- Location: Groningen, The Netherlands
- Total investments: 3
- Last investment: Jul 2023
- Lead investor: 33%
- Last updated: Aug 2026
- LinkedIn: https://nl.linkedin.com/in/annemiekewouterse
- X (Twitter): https://twitter.com/awouterse
- Website: https://x.com/awouterse
- Facebook: https://www.facebook.com/annemieke.wouterse

Annemieke Wouterse is a Senior Investment Manager at N.V. NOM, Investment and Development Company for the Northern Netherlands. Before joining NOM in 1999, Annemieke held various senior consultancy and controller roles in companies like Bakkenist, AVEBE and AkzoNobel. Annemieke is a Member of the Supervisory Board at Mucosis since September2010. Annemieke has a financial background and is involved with several highly innovative companies in the region. Annemieke holds a Bachelor's degree in Economics from Erasmus University Rotterdam as well as a Master's degree in Finance and Controller from Vrije Universiteit Amsterdam. Annemieke completed the supervisory board program at the Nyenrode Business University.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Diagnostics | 2 | 67% |
| Health Care | 1 | 33% |
| Therapeutics | 1 | 33% |
| Manufacturing | 1 | 33% |
| Medical Device | 1 | 33% |

6 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 33% |
| Pre-Seed | 1 | 33% |
| Funding Round | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Reyedar | Reyedar is a manufacturer of a medical tool intended to hasten the early detection of visual impairment and neurodegenerative disorders. They offer stress-free, non-invasive functional vision examinations to opticians, optometrists, ophthalmologists, and researchers. | $3.3M |  | Jul 05, 2023 |  |
| Reyedar | Reyedar is a manufacturer of a medical tool intended to hasten the early detection of visual impairment and neurodegenerative disorders. They offer stress-free, non-invasive functional vision examinations to opticians, optometrists, ophthalmologists, and researchers. | $3.3M | Seed | Jul 05, 2023 |  |
| Protyon | Protyon provides an analysis service examines the effect of mutations in specific proteins targeted for treatment in lung cancer. | $654.7K | Pre-Seed | May 11, 2023 |  |

3 of 3 investments shown.

## Co-investors
- [Blue Sparrows MedTech Funds](https://shizune.co/investors/profile/blue-sparrows-medtech-funds) — VC Fund, 2 deals together
- [Cottonwood Technology Fund](https://shizune.co/investors/profile/cottonwood-technology-fund) — VC Fund, 2 deals together
- [LUMO labs](https://shizune.co/investors/profile/lumo-labs) — VC Fund, 2 deals together
- [Pupil Labs](https://shizune.co/investors/profile/pupil-labs) — VC Fund, 2 deals together
- [Uneti Ventures](https://shizune.co/investors/profile/uneti-ventures) — VC Fund, 2 deals together

## About NV NOM

VC Fund · Groningen, The Netherlands

NOM is investing in the development of the Northern Netherlands. And you, the entrepreneur, good use. You can rely on us in all phases of your business. From the start until your organization is as good as grown. And even further to succession or acquisition.

2 contacts available at NV NOM.

| Name | Title | Profile |
| --- | --- | --- |
| Annemieke Wouterse | Senior Investment Manager | https://shizune.co/investors/profile/annemieke-wouterse |
| Ytsen van der Meer | Investment manager | https://shizune.co/investors/profile/ytsen-van-der-meer |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Annemieke Wouterse invest in?

Annemieke Wouterse invests primarily in Health Diagnostics, Health Care and Therapeutics startups, most often at Seed and Pre-Seed stage. Most of the 3 investments tracked by Shizune back companies in The Netherlands. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Annemieke Wouterse last invest?

The most recent investment recorded for Annemieke Wouterse closed in Jul 2023. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co